Similar articles

• Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.

  Beems T, Simons KS, Van Geel WJ, De Reus HP, Vos PE, Verbeek MM. Beems T, et al. Acta Neurochir (Wien). 2003 Jan;145(1):37-43. doi: 10.1007/s00701-002-1019-1. Acta Neurochir (Wien). 2003. PMID: 12545260
• Cerebrospinal fluid markers in neurological disorders.

  Massaro AR, Scivoletto G, Tonali P. Massaro AR, et al. Ital J Neurol Sci. 1990 Dec;11(6):537-47. doi: 10.1007/BF02337436. Ital J Neurol Sci. 1990. PMID: 1707039 Review.
• The value of studying the cerebrospinal fluid in slow viral and related diseases.

  Lowenthal A, Karcher D. Lowenthal A, et al. Ann N Y Acad Sci. 1994 Jun 6;724:68-74. doi: 10.1111/j.1749-6632.1994.tb38896.x. Ann N Y Acad Sci. 1994. PMID: 7518208 Review. No abstract available.
• Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica.

  Brisby H, Olmarker K, Rosengren L, Cederlund CG, Rydevik B. Brisby H, et al. Spine (Phila Pa 1976). 1999 Apr 15;24(8):742-6. doi: 10.1097/00007632-199904150-00003. Spine (Phila Pa 1976). 1999. PMID: 10222523
• [Neuron-specific enolase and S-100 protein levels in the cerebrospinal fluid of the patients with neurological diseases].

  Mokuno K, Kato K, Kawai K, Matsuoka Y, Sobue I. Mokuno K, et al. Rinsho Shinkeigaku. 1983 May;23(5):397-403. Rinsho Shinkeigaku. 1983. PMID: 6883882 Japanese. No abstract available.